CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats.

Journal of the American Society of Nephrology : JASN
M NangakuW G Couser

Abstract

CD59 is a cell membrane-bound complement regulatory protein on glomerular cells that inhibits C5b-9 assembly and insertion. This report describes a recently developed model of immune thrombotic microangiopathy (TMA) induced by the renal artery perfusion of anti-glomerular endothelial cell (anti-GEN) antibody. To examine the role of CD59 in protecting the GEN from immune-mediated injury, rats underwent selective renal artery perfusion with F(ab')2 fragments of anti-CD59 monoclonal antibody to block CD59 activity or control mouse IgG followed by anti-GEN antibody or control goat IgG. Neutralization of CD59 in normal rats did not result in any significant functional or histologic changes. Perfusion with anti-CD59 did not change deposition of the pathogenic anti-GEN IgG used to induce the TMA model. However, neutralization of CD59 in the TMA model resulted in more C5b-9 formation in glomeruli, accompanied by increased platelet and fibrin deposition, more severe endothelial injury, and reduced renal function compared with the animals perfused with control F(ab')2 fragments. These results demonstrate directly that CD59 serves a protective role for GEN in this TMA model of rats, and confirm that C5b-9 formation has a critical pathogen...Continue Reading

Citations

Aug 5, 1998·Current Opinion in Nephrology and Hypertension·M NangakuR J Johnson
Aug 26, 2003·Journal of the American Society of Nephrology : JASN·Daniel TurnbergH Terence Cook
Aug 26, 2003·Journal of the American Society of Nephrology : JASN·Masaomi Nangaku
Mar 4, 2021·BMJ Case Reports·Jennifer Jane GileMichael R Mueller
Nov 30, 1999·Journal of the American Society of Nephrology : JASN·M NangakuW G Couser
Dec 9, 1998·Kidney International·M Nangaku
Jan 3, 2001·Journal of the American Society of Nephrology : JASN·Brigitte SchillerRichard J Quigg
Sep 5, 2001·Kidney International·J A JeffersonW G Couser
Sep 20, 2001·Journal of the American Society of Nephrology : JASN·Jing ShaoMasaomi Nangaku
May 4, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Guohui RenRichard J Quigg
May 7, 1999·Kidney International·M Kitamura, L G Fine
Aug 8, 2002·Kidney International·Masaomi NangakuRichard J Johnson
Apr 23, 2002·Hypertension·Haruo MitaniRyozo Nagai
Jun 10, 2020·Laboratory Investigation; a Journal of Technical Methods and Pathology·Quan YuanLi Sun
Apr 9, 2005·Journal of the American Society of Nephrology : JASN·Te-Chao FangRichard Poulsom
Jul 19, 2005·Expert Opinion on Investigational Drugs·Masashi Mizuno, Duncan S Cole
Sep 29, 2005·Clinical and Experimental Nephrology·Masaomi Nangaku, William G Couser
Aug 30, 2005·Annals of the New York Academy of Sciences·Silvia S PierangeliGuillermina Girardi
Jun 30, 2005·Arthritis and Rheumatism·Silvia S PierangeliJane Salmon
Aug 12, 2005·Journal of the American Society of Nephrology : JASN·Nobuaki EtoMasaomi Nangaku
Jun 16, 2006·Kidney International·N BesbasUNKNOWN European Paediatric Research Group for HUS
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Noriko UesugiHiroshi Iwasaki
Jun 27, 2007·Clinical and Experimental Nephrology·Masaomi NangakuToshiro Fujita
Apr 18, 2008·American Journal of Physiology. Renal Physiology·Haiping MaoXueqing Yu
May 21, 2008·Lupus·J E Salmon, P G de Groot
May 25, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lan XuJi Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.